Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
KRAS wild-type Metastatic Colorectal Cancer, Squamous Cell Carcinoma of the Head and Neck, and Non-Small Cell Lung Cancer.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Testicular, Ovarian, Bladder, Lung, Colorectal, Gastric, and Head & Neck Cancers.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Relapsed/refractory Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Small Cell Lung Cancer, or Acute Lymphoblastic Leukemia.